Prognos Health – Unlocking the power of data to improve health

Transactional health data has long been the foundation of healthcare analytics. But alone, it has serious analytical limitations — on prognoses, trials, outcomes, and commercial education. To truly improve healthcare and make the most informed decisions, we need to factor in all of the data born from the patient journey. And the most influential dataset is lab results. Real-world data is important because it enables researchers to go beyond data gathered throughout a traditional RCT. Because traditional RCTs gather data from a controlled sample population, their findings can be limited by the characteristics of the cohort examined in the trial. Additionally, RCTs usually require significant investment and time for data to accumulate. RWD, on the other hand, can be collected from any number of cohorts or population sub-groups. The insights gained from such data can be extraordinarily valuable. Examining the use of a new medication or treatment protocol in special populations in real-world settings where patient’s behavior, co-occurring treatments and environmental factors are not influenced by participation in an RCT can provide powerful insights.

Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care. A decade ago, Prognos Health leveraged its clinical and analytical expertise to develop a solution that completes the analytical picture — transforming diagnostic and transactional data into insight-ready information. And it developed that solution to harness machine learning to teach itself to work even smarter over time.

Accelerate value across the commercial lifecycle with healthcare data

Today companies are drowning in data, and they always seem to need more data. Yet taking on more assets has become a huge expense and burden for many of their clients. Healthcare data needs constant upkeep to make it purpose-ready. It needs to be accurate, compliant and ready to analyze. It is a new and better way to buy healthcare data. Explore, purchase and benefit from the largest source of lab test results, closed medical claims and Rx data.

Purchasing, integrating and analyzing de-identified patient data to drive clinical and commercial efforts has historically been time-consuming, expensive, and difficult to manage — for buyers and sellers alike. From contract management to purchase constraints, the process to reach patient insights for better outcomes has been fraught with hurdles.

Prognos Marketplace uniquely houses harmonized lab test results from trusted sources integrated with large sources of Rx and medical claims. There are more than 45 billion health records for 325 million de-identified patients with new data sources being added continually. Users can create and refine patient cohorts and then buy healthcare data through a single contract. All data purchased is available on the Datavant token, making it interoperable with other patient-level data that has been tokenized using Datavant. Now there’s a better way of exploring and purchasing record level, de-identified patient data from the most trusted sources.

From R&D through growth, their products help provide a more complete view of the patient and customer to support launch excellence and commercial success. You know Prognos for their data-driven lab-based solutions. Now, they have a Marketplace that includes medical and prescription claims, and with a token from their partner, Datavant, Prognos Factor can integrate any data you need, including your own assets, to accelerate time to insight. Users can access healthcare data that can support your tactical efforts across the entire commercial lifecycle. Their software drives the clinical specificity you need to improve outcomes and reach the patients and practitioners who can benefit from earlier intervention. Alerts drive optimized outreach to physicians before they make a treatment decision. Physicians continue to become more elusive — from ‘no see’ status to restrictions driven by the pandemic. Now more than ever, brand teams are seeking alternatives to static call plans and schedule-based, non-personal promotion and advertising.

Stop wasting resources and budget placing non-branded or brand advertisements on sites physicians simply frequent. While they may see your ad, the relevance and timing might not be right. What if you could reach a physician across channels based on the timing of a treatment decision for a patient that is eligible for your brand? Leveraging Prognos Factor’s near-real-time clinically-focused insights and pharmaceutical omnichannel software, it’s possible.

Sundeep Bhan | Co-Founder & Chief Executive Officer

Sundeep Bhan is an accomplished serial entrepreneur committed to leveraging technology to enhance healthcare. He currently holds the position of CEO and Co-founder at Prognos Health, a company that is unlocking the power of data to improve health. Prior to this, Bhan co-founded Medsite, Inc., which attracted investment from renowned firms like JP Morgan Partners, Bain, Morgan Stanley, and Reuters. He later sold the company to WebMD in 2006.

Mr. Bhan is a Senior Advisory Board member at Consonance Capital Partners, a private equity fund, and also serves on the Board of Directors for the VIA Institute on Character. Previously, he was a non-faculty Lecturer at Wharton, where he taught Healthcare Entrepreneurship. Bhan is a highly regarded influencer in digital health and frequently speaks at industry conferences and events, such as SXSW and JP Morgan. Bhan is a proud alumnus of the University of Pennsylvania.

"Prognos Marketplace uniquely houses harmonized lab test results from trusted sources integrated with large sources of Rx and medical claims."